Literature DB >> 11222681

Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

D Salamon1, M Takacs, D Ujvari, J Uhlig, H Wolf, J Minarovits, H H Niller.   

Abstract

Epstein-Barr viral (EBV) latency-associated promoters Qp, Cp, and LMP1p are crucial for the regulated expression of the EBNA and LMP transcripts in dependence of the latency type. By transient transfection and in vitro binding analyses, many promoter elements and transcription factors have previously been shown to be involved in the activities of these promoters. However, the latency promoters have only partially been examined at the nucleotide level in vivo. Therefore, we undertook a comprehensive analysis of in vivo protein binding and CpG methylation patterns at these promoters in five representative cell lines and correlated the results with the known in vitro binding data and activities of these promoters from previous transfection experiments. Promoter activity inversely correlated with the methylation state of promoters, although Qp was a remarkable exception. Novel protein binding data were obtained for all promoters. For Cp, binding correlated well with promoter activity; for LMP1p and Qp, binding patterns looked similar regardless of promoter activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222681      PMCID: PMC115881          DOI: 10.1128/JVI.75.6.2584-2596.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  112 in total

1.  Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.

Authors:  J Sample; L Brooks; C Sample; L Young; M Rowe; C Gregory; A Rickinson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.

Authors:  F Wang; H Kikutani; S F Tsang; T Kishimoto; E Kieff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.

Authors:  J Minarovits; S Minarovits-Kormuta; B Ehlin-Henriksson; K Falk; G Klein; I Ernberg
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

4.  Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer.

Authors:  H H Niller; L Hennighausen
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

5.  Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.

Authors:  U Zimber-Strobl; K O Suentzenich; G Laux; D Eick; M Cordier; A Calender; M Billaud; G M Lenoir; G W Bornkamm
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.

Authors:  N S Sung; S Kenney; D Gutsch; J S Pagano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.

Authors:  R Fåhraeus; A Jansson; A Ricksten; A Sjöblom; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.

Authors:  L F Hu; J Minarovits; S L Cao; B Contreras-Salazar; L Rymo; K Falk; G Klein; I Ernberg
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.

Authors:  M Woisetschlaeger; X W Jin; C N Yandava; L A Furmanski; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

10.  Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter.

Authors:  D Walls; M Perricaudet
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  19 in total

1.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro.

Authors:  Feng-Wei Wang; Xian-Rui Wu; Wen-Ju Liu; Ying-Jie Liang; Yu-Fan Huang; Yi-Ji Liao; Chun-Kui Shao; Yong-Sheng Zong; Shi-Juan Mai; Dan Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-07       Impact factor: 2.503

3.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.

Authors:  Charles M Chau; Paul M Lieberman
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Authors:  Agnes Bakos; Ferenc Banati; Anita Koroknai; Maria Takacs; Daniel Salamon; Susanna Minarovits-Kormuta; Fritz Schwarzmann; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Virus Genes       Date:  2007-05-18       Impact factor: 2.332

6.  Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.

Authors:  Charles M Chau; Xiao-Yong Zhang; Steven B McMahon; Paul M Lieberman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.

Authors:  Alexander M Price; Joshua E Messinger; Micah A Luftig
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

8.  High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.

Authors:  Daniel Salamon; Maria Takacs; Fritz Schwarzmann; Hans Wolf; Janos Minarovits; Hans Helmut Niller
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

9.  Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Authors:  Borbala Gerle; Anita Koroknai; György Fejer; Agnes Bakos; Ferenc Banati; Kalman Szenthe; Hans Wolf; Hans Helmut Niller; Janos Minarovits; Daniel Salamon
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 10.  Epigenetic regulation of EBV and KSHV latency.

Authors:  Horng-Shen Chen; Fang Lu; Paul M Lieberman
Journal:  Curr Opin Virol       Date:  2013-04-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.